-

• Drug delivery in acute and chronic wounds
• Protein Delivery for Wound Healing Phases
  • Growth Factors
• Injectable Implants
  • Long-term controlled release
• Ocular Drug Delivery
  • Conjunctival sac delivery
  • Eye orbital implants

• Self-assembling conjunctival implant. Erodible or non-erodible
  • Self-assembling, soft drug delivery implant formed in conjunctival sac from eye drops.
  • Drug release is tailored to the application
• Injectable orbital implant allowing placement in the Tenons capsule.
  • Can be placed near the optic nerve
  • Can be placed near wounds or infections in the scleral wall
• Scleral Buckle impregnated with antibiotic
  • Pre formed buckles
  • Injectable buckles

• On administration of the eye drop into the conjunctival sac immediately on contact with body fluids the eye drop fluid will irreversible coalesce to form a self assembling implant.
• Material conforms to the shape of the conjunctival sac area.
• The material characteristics of the implant can be designed to the intended application
• The material is significantly softer than implantable drug delivery devices
• Drug release rates can be tailored over 30 days or longer depending on the amount of drug required
• Permanent implant material can be easily removed after application.

• Drug delivery can be tailored to specific applications
• Material is formed of contact lens hydrogel polymer with long history of safety and ocular tolerance
• Hydrogel offers ease of application and drug delivery rates of up to one year